Drug Database
Back to search

Belgium· BE-AMP-SAM149511-00

Cipralan 130 mg

A cibenzoline product containing cibenzoline succinate, registered in Belgium by Continental Pharma. The same ATC class is registered in 3 of our 19 countries.

ATC C01BG07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCipralan 130 mgATCC01BG07REGISTER NO.BE-AMP-SAM149511-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cibenzoline succinateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cibenzoline is registered in 3 of 19 countries.

Countries holding a registration under ATC C01BG07 (cibenzoline), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose
Search cibenzoline products by name

Cibenzoline · ATC C01BG07

3 / 19 countries

  • Belgiumprice
  • Franceprice
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Cibenzoline Succinate
Manufacturer
Continental Pharma
Country
Belgium (BE)
ATC code
C01BG07
ATC class
Cibenzoline
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    0493023
  • be_apb
    0493031
  • be_apb
    0736181

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cibenzoline in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cibenzoline products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • France · Exacor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a7eb0d10-d86f-4815-8f52-c6b1b9a17ac1
GET /v1/drugs/a7eb0d10-d86f-4815-8f52-c6b1b9a17ac1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Cipralan 130 mg",
  "name_fr": "Cipralan 130 mg",
  "name_nl": "Cipralan 130 mg",
  "amp_code": "SAM149511-00",
  "strengths": [
    "188.4600",
    "188.4600",
    "130.0000",
    "130.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Cibenzoline Succinate",
    "Cibenzoline"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cibenzoline",
  "authorisation_numbers": [
    "0213IS0018F003"
  ]
}
API referenceMCP serverPlans

See everything about cibenzoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console